StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.82+0.02 (+0.10%)

Close on Nov 18, 2026Market cap $936.43MP/E –Yield –

Silence Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Silence Therapeutics's total assets was $281.50M at Sep 30, 2026. For fiscal 2025 it was $131.44M, down 35.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$131.44M-35.1%
FY2024Dec 31, 2024$202.64M+69.6%
FY2023Dec 31, 2023$119.45M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$281.50M+91.8%
Q2 FY2026Jun 30, 2026$106.41M-35.6%
Q1 FY2026Mar 31, 2026$115.12M-37.9%
Q4 FY2025Dec 31, 2025$131.44M-35.1%
Q3 FY2025Sep 30, 2025$146.79M+22.9%
Q2 FY2025Jun 30, 2025$165.23M–
Q1 FY2025Mar 31, 2025$185.30M–
Q4 FY2024Dec 31, 2024$202.64M–
Q4 FY2023Dec 31, 2023$119.45M–

More Silence Therapeutics figures

See a number that looks wrong?